Gravity Analytica

Outset Medical to Report Third Quarter 2024 Financial Results on Wednesday, November 6, 2024

OM 10.23.2024

SERA-AI Powered Highlights

Date of Upcoming Event:2024-11-06

Name of Upcoming Event:Conference Call

Full Press Release SEC Filings Our OM Tweets

About Gravity Analytica

Recent Filings

PDF Version

SAN JOSE, Calif.,Oct. 23, 2024(GLOBE NEWSWIRE) --Outset Medical, Inc.(Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that it will release financial results for the third quarter of 2024 after the close of trading onWednesday, November 6, 2024.

On the same day, at2:00 p.m. Pacific time(5:00 p.m. Eastern time),Leslie Trigg, Chair and Chief Executive Officer, andNabeel Ahmed, Chief Financial Officer, will host a conference call to discuss financial and operating results.

Conference Call DetailsThe conference call will begin at2:00 p.m. Pacific time(5:00 p.m. Eastern time) onWednesday, November 6, 2024. Those interested in listening to the conference call may do so byregistering online. Once registered, participants will receive dial-in numbers and a unique pin to join the call. Participants are encouraged to register more than 15 minutes before the start of the call. A live and archived webcast of the event will be available on the “Investors” section of the Outset website athttps://investors.outsetmedical.com/.

AboutOutset Medical, Inc.Outset is a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis. The Tablo® Hemodialysis System, FDA cleared for use from the hospital to the home, represents a significant technological advancement that transforms the dialysis experience for patients and operationally simplifies it for providers. Tablo serves as a single enterprise solution that can be utilized across the continuum of care, allowing dialysis to be delivered anytime, anywhere and by anyone. The integration of water purification and on-demand dialysate production enables Tablo to serve as a dialysis clinic on wheels, with 2-way wireless data transmission and a proprietary data analytics platform powering a new holistic approach to dialysis care. Tablo is a registered trademark ofOutset Medical, Inc.

ContactJim MazzolaInvestor Relationsjmazzola@outsetmedical.com

Source: Outset Medical, Inc.

Please be aware that the following content has been generated by an AI system and may contain errors, inconsistencies, or outdated information. It is provided as-is without any warranties or guarantees of accuracy. We strongly recommend using this content as a starting point for further research and consultation with relevant experts or authorities. We disclaim any liability for damages or losses resulting from the use or reliance on this content.Please note that this is a beta version of the Gravity Analytica LLC’s AI Service which isstill undergoing final testing before its official release. Theplatform, its software and all content found on it are provided on an“as is” and “as available” basis. Gravity Analytica LLC does not give any warranties,whether express or implied, as to the suitability or usability of thisservice, webpage, or its software or any of its content.Should you encounter any bugs, glitches, lack of functionality orother problems on the website, please let us know immediately so wecan rectify these accordingly. Your help in this regard is greatlyappreciated! You can write to us at this addressteam@gravityanalytica.com